Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,184,000 | 3,683,000 | 2,749,000 | 2,295,000 | 1,125,000 |
| Depreciation Amortization | 259,000 | 1,060,000 | 799,000 | 534,000 | 273,000 |
| Income taxes - deferred | N/A | -328,000 | N/A | N/A | N/A |
| Accounts receivable | -92,000 | -557,000 | -386,000 | -369,000 | -181,000 |
| Accounts payable and accrued liabilities | 226,000 | -95,000 | -5,000 | 121,000 | 104,000 |
| Other Working Capital | -613,000 | 294,000 | -289,000 | -401,000 | -459,000 |
| Other Operating Activity | 8,000 | 1,062,000 | 667,000 | 386,000 | 168,000 |
| Operating Cash Flow | $972,000 | $5,119,000 | $3,535,000 | $2,566,000 | $1,030,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,233,000 | 437,000 | 467,000 | 1,220,000 | -46,000 |
| PPE Investments | -144,000 | -567,000 | -343,000 | -223,000 | -100,000 |
| Net Acquisitions | -969,000 | -701,000 | -701,000 | -701,000 | -403,000 |
| Other Investing Activity | 0 | 45,000 | 11,000 | -5,000 | -6,000 |
| Investing Cash Flow | $-2,346,000 | $-786,000 | $-566,000 | $291,000 | $-555,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 762,000 | N/A | N/A | N/A |
| Debt Issued | N/A | 10,387,000 | 2,973,000 | 2,973,000 | N/A |
| Debt Repayment | -84,000 | -2,500,000 | -2,500,000 | -2,500,000 | -2,500,000 |
| Common Stock Issued | 374,000 | 242,000 | 126,000 | 113,000 | 16,000 |
| Common Stock Repurchased | -1,375,000 | -8,315,000 | -3,017,000 | -745,000 | -14,000 |
| Dividend Paid | -285,000 | -500,000 | -255,000 | N/A | N/A |
| Other Financing Activity | 5,000 | -750,000 | 308,000 | 13,000 | 2,000 |
| Financing Cash Flow | $-1,365,000 | $-674,000 | $-2,365,000 | $-146,000 | $-2,496,000 |
| Beginning Cash Position | 6,946,000 | 3,287,000 | 3,287,000 | 3,287,000 | 3,287,000 |
| End Cash Position | 4,207,000 | 6,946,000 | 3,891,000 | 5,998,000 | 1,266,000 |
| Net Cash Flow | $-2,739,000 | $3,659,000 | $604,000 | $2,711,000 | $-2,021,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 972,000 | 5,119,000 | 3,535,000 | 2,566,000 | 1,030,000 |
| Capital Expenditure | -144,000 | -567,000 | -343,000 | -223,000 | -100,000 |
| Free Cash Flow | 828,000 | 4,552,000 | 3,192,000 | 2,343,000 | 930,000 |